BANK OF AMERICA CORP /DE/ - DOVA PHARMACEUTICALS INC ownership

DOVA PHARMACEUTICALS INC's ticker is DOVA and the CUSIP is 25985T102. A total of 58 filers reported holding DOVA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of DOVA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$894,000
+243.8%
31,971
+73.4%
0.00%
Q2 2019$260,000
+251.4%
18,440
+122.3%
0.00%
Q1 2019$74,000
-3.9%
8,295
-17.6%
0.00%
Q4 2018$77,000
-66.7%
10,070
-8.4%
0.00%
Q3 2018$231,000
+45.3%
10,998
+107.3%
0.00%
Q2 2018$159,000
+101.3%
5,305
+81.3%
0.00%
Q1 2018$79,000
-39.7%
2,926
-35.7%
0.00%
Q4 2017$131,000
+2083.3%
4,554
+1797.5%
0.00%
Q3 2017$6,0002400.00%
Other shareholders
DOVA PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Perceptive Advisors 3,125,851$23,693,0000.90%
Broadfin Capital, LLC 351,800$2,667,0000.35%
Birchview Capital, LP 40,000$303,0000.29%
SPHERA FUNDS MANAGEMENT LTD. 185,000$1,402,0000.16%
Fosun International Ltd 261,780$1,984,0000.12%
Spark Investment Management LLC 61,100$463,0000.03%
Candriam S.C.A. 233,200$1,768,0000.03%
GW&K Investment Management, LLC 178,536$1,353,0000.03%
Tower Research Capital LLC (TRC) 20,613$156,0000.01%
Point72 Hong Kong Ltd 1,456$11,0000.01%
View complete list of DOVA PHARMACEUTICALS INC shareholders